Medicines UK

Medicines UK is the trade body representing the manufacturers and suppliers of 85% of the prescription medicines used by the NHS. Via competition, these essential generic, biosimilar and value-added medicines deliver more than £20 billion in annual savings to healthcare budgets. This allows more patients to access the treatments they need.

 

Without generic or biosimilar medicines, the NHS would simply be unsustainable, as the competition created by off-patent companies delivers billions of annual savings. This means the UK benefits from the lowest medicine prices in Europe.

 

As well as savings, off-patent competition allows more patients to be treated, increasing access and often allowing earlier intervention in a treatment pathway.